2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
16
Breast
7
Other
3
Tumor-Agnostic
1
Lymphoid
1
Gastrointestinal
1
Endocrine
1
Conditions
Sarcopenia
1
Eunuchism
1
Colorectal Neoplasms
1
Interventions
Oxaliplatin
1435
Fluorouracil
1316
Capecitabine
1112
Gemcitabine
1054
Leucovorin
935
Bevacizumab
845
Irinotecan
827
Cisplatin
673
Radiotherapy
559
Cetuximab
481
pembrolizumab
435
Paclitaxel
400
Drug Therapy
358
Nivolumab
349
130-nm albumin-bound paclitaxel
326
Docetaxel
289
Sorafenib
288
S 1 (combination)
278
Folfox protocol
266
Albumin-Bound Paclitaxel
263
Surgical Procedures, Operative
256
lenvatinib
222
sintilimab
218
tislelizumab
213
durvalumab
211
regorafenib
208
Radiosurgery
204
Magnetic Resonance Spectroscopy
203
apatinib
202
Neoadjuvant Therapy
190
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testosterone
×
Gastrointestinal
×
Clear all
NCT05367284
2022-05-10
TERESA
London North West Healthcare NHS Trust
Unknown
30 enrolled